{"transactions":[{"id":2373875,"issuer":{"id":7122,"kind":"organization","name":"Xilio Therapeutics, Inc."},"owners":[{"id":129999,"kind":"person","name":"Giovine Salvatore","position":1,"cik":"0001887790","reported_name":"Giovine Salvatore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-24T22:30:34.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":49500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was granted on February 22, 2022 and shall vest on March 1, 2022 with respect to 1/48th of the shares of common stock underlying the stock option and continue to vest in equal monthly installments thereafter until February 1, 2026."}],"balance_after":49500,"derivative":{"exercise_price":12.66,"expiration_date":"2032-02-21","underlying":"Common Stock","underlying_shares":49500},"source":{"system":"sec-edgar","filing":"0001415889-22-001793","document":"form4-02242022_050215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840233/000141588922001793/form4-02242022_050215.xml","form_type":"4"}},{"id":2535345,"issuer":{"id":7122,"kind":"organization","name":"Xilio Therapeutics, Inc."},"owners":[{"id":129999,"kind":"person","name":"Giovine Salvatore","position":1,"cik":"0001887790","reported_name":"Giovine Salvatore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-10-25T21:16:55.000Z","date":"2021-10-21","kind":"grant","acquired":true,"shares":28755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was granted on October 21, 2021 and shall begin to vest on November 1, 2021 and continue to vest in equal monthly installments thereafter until October 1, 2025."}],"balance_after":28755,"derivative":{"exercise_price":16,"expiration_date":"2031-10-20","underlying":"Common Stock","underlying_shares":28755},"source":{"system":"sec-edgar","filing":"0001104659-21-129565","document":"tm2130646-20_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840233/000110465921129565/tm2130646-20_4seq1.xml","form_type":"4"}}]}